Rhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations
Open Access
- 10 March 2021
- journal article
- research article
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2021, 1-6
Abstract
Background. Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2). Conclusion. Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.Keywords
This publication has 16 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Calcium Ions Directly Interact with the Ebola Virus Fusion Peptide To Promote Structure–Function Changes That Enhance InfectionACS Infectious Diseases, 2019
- Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cellsVirology, 2018
- Rhabdomyolysis: Review of the literatureNeuromuscular Disorders, 2014
- Hypocalcemia: updates in diagnosis and management for primary care.2012
- Rhabdomyolysis: pathogenesis of renal injury and managementPediatric Nephrology, 2011
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009
- Bacterial, Fungal, Parasitic, and Viral MyositisClinical Microbiology Reviews, 2008
- RhabdomyolysisInternal and Emergency Medicine, 2007
- Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in ratsDiabetologia, 1998